HCPLive Network
Latest Oncology Headlines
By Adam Hochron
As the practice of telecare continues to gain momentum, a group of researchers conducted a study to test how effective that course of treatment is in patients with chronic illnesses.
By Andrew L. Pecora, MD
There is a growing chorus that seems to be debating separate issues—340B drug pricing, the sequester, site of service differential, etc. But the debate revolves around a singular issue—where should cancer care be delivered?
Patients with cancer and depression frequently do not receive effective treatment; however, an integrated program is effective in patients with cancer, and specifically lung cancer, according to three studies published online Aug. 28 in The Lancet Psychiatry, The Lancet, and The Lancet Oncology.
Treatment-naive patients with multiple myeloma frequently have sensory deficits, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
Patients with polycythemia vera can be classified according to disease behavior, independently of Janus kinase 2 V617F allele burden, after removing sex as a potential confounder, according to a study published in the Aug. 28 issue of the New England Journal of Medicine.
Focal liver lesions are mostly benign, and can be diagnosed based on knowledge of their presentation, associated clinical and laboratory features, and natural history, according to clinical guidelines published online Aug. 19 in the American Journal of Gastroenterology.
By Beth Fand Incollingo
Sipuleucel-T (Provenge) is effective when given either before or after androgen deprivation therapy (ADT) in men with biochemically recurrent prostate cancer (BRPC) who face a high risk of developing metastases, a study has found.
For patients who undergo removal of adenomas, colorectal cancer mortality risk is increased for those who had high-risk adenomas removed and reduced for those who had low-risk adenomas removed, according to a study published in the Aug. 28 issue of the New England Journal of Medicine.
By Tony Berberabe, MPH
Although advances in endocrine therapy for women with estrogen receptor (ER)-positive breast cancer have been made in recent years, de novo and acquired resistance to treatments remain important clinical problems, and efforts to identify effective modalities to overcome this challenge continue.
The increasing administrative requirements of a medical practice are requiring a team-based approach to care, and physicians must learn to manage the team, according to an article published Aug. 7 in Medical Economics.
By Andrew J. Roth
Advaxis and Merck have entered into a clinical trial collaboration agreement to evaluate the combination of two novel immunotherapies for the treatment of patients with metastatic castration-resistant prostate cancer.
By Arjun Vasant Balar, MD
A major step toward improved tolerability of cisplatin-based therapy came in the early 2000s with the advent of the modern regimen of gemcitabine and cisplatin.
Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
By Andrew Smith
In ever-growing body of research confirms what many oncologists have long suspected: the stresses of their profession produce an alarming rate of burnout.
For patients with first unprovoked venous thromboembolism, aspirin after anticoagulant treatment reduces the risk of recurrence, according to a study published online Aug. 25 in Circulation.
By Maurie Markman, MD
Scarcely a week goes by without a report in the peer-reviewed medical literature suggesting that a novel somatic genomic alteration or a specific normal polymorphism is potentially relevant to achieving a desirable clinical outcome within cancer medicine.
By Silas Inman
Treatment with KTE-C19, a CD19-targeted CAR-modified T cell therapy, demonstrated an objective response rate of 92% in patients with advanced B-cell malignancies.
By Gale Scott
The nation’s youth, and its smoke-free air need federal protection from vapors from e-cigarettes, according to a set of recommendations released Aug. 25 by the American and Heart Association.
By Silas Inman
The FDA has approved eltrombopag as a treatment for patients with severe aplastic anemia following an insufficient response to immunosuppressive therapy.
By Beth Fand Incollingo
A physician’s perspective, and the therapies he most often prescribes, can have a big influence on whether his patients with low-risk prostate cancer are treated or put on active surveillance, a study has found.
Physician's Money Digest
Medical research funding is critical, but many promising startups never reach clinical stages due to a lack of funds. However, the path has opened up for even the average investor.
After years of delayed gratification, most young physicians transitioning from residency or fellowship into practice want to buy a house they will be happy living in.